Loading
Loading…
Loading…
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
8 Aug 2026, 10:00 am
Medicine
9625555
GEM/2026/B/7803639
Two Packet Bid
Tab Liv 52,InjRabipur,InjEptoin2 ml,InjLevera100 mg,Sample collection test tube EDTA,Sample collect
Jalpaiguri, West Bengal
Total value wise evaluation
BOQ
7 documents required · 7 mandatory
3 yrs
₹2 L
₹2 L
10%
Exempted
Yes
17 Jul 2026
17 Jul 2026
8 Aug 2026
| Item No | Item Title | Description | Qty | Unit | Consignee | Delivery (days) |
|---|---|---|---|---|---|---|
| 1 | Tab Liv 52 | Himalaya | 2,000 | Nos | DCQMADV030 | 10 |
| 2 | InjRabipur | Chiron Behring Vaccines Pvt. Ltd | 30 | Vial | DCQMADV030 | 10 |
| 3 | InjEptoin2 ml | Abbot | 20 | Amp | DCQMADV030 | 10 |
| 4 | InjLevera100 mg | Intas | 20 | Vial | DCQMADV030 | 10 |
| 5 | Sample collection test tube EDTA | Nasmed | 2,000 | Nos | DCQMADV030 | 10 |
| 6 | Sample collection test tube Clot Activator Red Top | Nasmed | 2,000 | Nos | DCQMADV030 | 10 |
| 7 | Lotion Caladryl65 ml | Piramal | 50 | Bottle | DCQMADV030 | 10 |
| 8 | Tab Telma AM | Glenmark Pharmaceuticals Ltd | 750 | Nos | DCQMADV030 | 10 |
| 9 | Tan Pantop 40 mg | Aristro | 1,500 | Nos | DCQMADV030 | 10 |
| 10 | Tab Avil 25 mg | Sanofi Consumer Health Care | 3,000 | Nos | DCQMADV030 | 10 |
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_9625555.pdf
GEM_BID • 0.15 MB
docscanner_17_jul_2026_7-13-pm_2026-07-17-20-42-41_61313af541cf0bc1b92c8ec6049a4acf.pdf
BOQ • 1.19 MB
boq_item_sample_file_-5_2026-07-17-20-42-41_7b67d419fba2937484e8ae8231ff30f7.csv
BOQ • 0.00 MB
gtc.pdf
GEM_OTHER • 0.71 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at [email protected].